CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
EmboSure is an innovative treatment for knee osteoarthritis that provides long-term pain relief and halts disease progression for up to five years. It uses bioresorbable particles to block small blood vessels in the knee, disrupting the degradation process of the joint.
EmboSure is a breakthrough treatment for Knee Osteoarthritis.
It acts directly on the mechanism of Osteoarthritis, delivers long term pain relief and stops the progression of the disease for up to 5 years.
The solution involves embolising or blocking the tiny blood vessels of the knee with patented bioresorbable particles developed by CrannMed.
The bioresorbable embolic particles are tightly calibrated 200µm particles, made from naturally occurring biocompatible materials which block the small b…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 topics.
Guests see up to 5 keywords.
